Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity

被引:13
作者
Gilio, Luana [1 ]
Buttari, Fabio [1 ]
Pavone, Luigi [1 ]
Iezzi, Ennio [1 ]
Galifi, Giovanni [1 ]
Dolcetti, Ettore [1 ]
Azzolini, Federica [1 ]
Bruno, Antonio [1 ]
Borrelli, Angela [1 ]
Storto, Marianna [1 ]
Furlan, Roberto [2 ]
Finardi, Annamaria [2 ]
Pekmezovic, Tatjana [3 ,4 ]
Drulovic, Jelena [3 ,5 ]
Mandolesi, Georgia [6 ,7 ]
Fresegna, Diego [6 ]
Vanni, Valentina [6 ]
Centonze, Diego [1 ,8 ]
Bassi, Mario Stampanoni [1 ]
机构
[1] IRCCS Neuromed, I-86077 Pozzilli, Italy
[2] Ist Sci San Raffaele, Inst Expt Neurol INSpe, Div Neurosci, Clin Neuroimmunol Unit, I-20132 Milan, Italy
[3] Univ Belgrade, Fac Med, Belgrade 11000, Serbia
[4] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade 11000, Serbia
[5] Clin Ctr Serbia, Clin Neurol, Belgrade 11000, Serbia
[6] IRCCS San Raffaele Roma, Synapt Immunopathol Lab, I-00163 Rome, Italy
[7] Univ Rome San Raffaele, Dept Human Sci & Qual Life Promot, I-00166 Rome, Italy
[8] Tor Vergata Univ, Dept Syst Med, I-00133 Rome, Italy
关键词
relapsing-remitting multiple sclerosis (RR-MS); fatigue; inflammation; IL-10; NEDA-3; T2 lesion load; MESSENGER-RNA; LESION LOAD; INFLAMMATION; IMPAIRMENT; DISABILITY; DIAGNOSIS; SCALE; PAIN;
D O I
10.3390/biomedicines10092058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In multiple sclerosis (MS), fatigue is a frequent symptom that negatively affects quality of life. The pathogenesis of fatigue is multifactorial and inflammation may play a specific role. To explore the association between fatigue, central inflammation and disease course in MS in 106 relapsing-remitting (RR)-MS patients, clinical characteristics, including fatigue and mood, were explored at the time of diagnosis. NEDA (no evidence of disease activity)-3 status after one-year follow up was calculated. Cerebrospinal fluid (CSF) levels of a set of proinflammatory and anti-inflammatory molecules and peripheral blood markers of inflammation were also analyzed. MRI structural measures were explored in 35 patients. A significant negative correlation was found at diagnosis between fatigue measured with the Modified Fatigue Impact Scale (MFIS) and the CSF levels of interleukin (IL)-10. Conversely, no significant associations were found with peripheral markers of inflammation. Higher MFIS scores were associated with reduced probability to reach NEDA-3 status after 1-year follow up. Finally, T2 lesion load showed a positive correlation with MFIS scores and a negative correlation with CSF IL-10 levels at diagnosis. CSF inflammation, and particularly the reduced expression of the anti-inflammatory molecule IL-10, may exacerbate fatigue. Fatigue in MS may reflect subclinical CSF inflammation, predisposing to greater disease activity.
引用
收藏
页数:13
相关论文
共 46 条
[1]   Fatigue in Multiple Sclerosis: Is it related to cytokines and hypothalamic-pituitary-adrenal axis? [J].
Akcali, Aylin ;
Zengin, Fatma ;
Aksoy, Sefika Nur ;
Zengin, Orhan .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 15 :37-41
[2]   Fatigue favors in vitro Th1 and Th17-like cell expansion and reduces corticoid sensitivity in MS patients [J].
Alvarenga-Filho, Helcio ;
Salles, Marisa ;
Hygino, Joana ;
Ferreira, Thais B. ;
Sacramento, Priscila M. ;
Monteiro, Clarice ;
Vasconcelos, Claudia Cristina F. ;
Papais Alvarenga, Regina Maria ;
Bento, Cleonice A. M. .
JOURNAL OF NEUROIMMUNOLOGY, 2017, 303 :81-89
[3]   Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology (vol 90, pg 777, 2018) [J].
Rae-Grant, A. ;
Day, G. S. ;
Marrie, R. A. .
NEUROLOGY, 2019, 92 (02) :112-112
[4]  
[Anonymous], 2007, Leading-Edge Psychological Tests and Testing Research
[5]   Fatigue in multiple sclerosis: Cross-sectional correlation with brain MRI findings in 71 patients [J].
Bakshi, R ;
Miletich, RS ;
Henschel, K ;
Shaikh, ZA ;
Janardhan, V ;
Wasay, M ;
Stengel, LM ;
Ekes, R ;
Kinkel, PR .
NEUROLOGY, 1999, 53 (05) :1151-1153
[6]   Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course [J].
Bassi, Mario Stampanoni ;
Iezzi, Ennio ;
Landi, Doriana ;
Monteleone, Fabrizia ;
Gilio, Luana ;
Simonelli, Ilaria ;
Musella, Alessandra ;
Mandolesi, Georgia ;
De Vito, Francesca ;
Furlan, Roberto ;
Finardi, Annamaria ;
Marfia, Girolama A. ;
Centonze, Diego ;
Buttari, Fabio .
JOURNAL OF NEUROLOGY, 2018, 265 (11) :2540-2547
[7]   Fatigue in multiple sclerosis: Associations with clinical, MRI and CSF parameters [J].
Biberacher, Viola ;
Schmidt, Paul ;
Selter, Rebecca C. ;
Pernpeinter, Verena ;
Kowarik, Markus C. ;
Knier, Benjamin ;
Buck, Dorothea ;
Hoshi, Muna-Miriam ;
Korn, Thomas ;
Berthele, Achim ;
Kirschke, Jan S. ;
Zimmer, Claus ;
Hemmer, Bernhard ;
Muehlau, Mark .
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (08) :1115-1125
[8]   Depression and fatigue in multiple sclerosis: Relation to exposure to violence and cerebrospinal fluid immunomarkers [J].
Brenner, Philip ;
Granqvist, Mathias ;
Konigsson, Johan ;
Al Nimer, Faiez ;
Piehl, Fredrik ;
Jokinen, Jussi .
PSYCHONEUROENDOCRINOLOGY, 2018, 89 :53-58
[9]   Fatigue predicts disease worsening in relapsing-remitting multiple sclerosis patients [J].
Cavallari, Michele ;
Palotai, Miklos ;
Glanz, Bonnie I. ;
Egorova, Svetlana ;
Prieto, Juan Carlos ;
Healy, Brian C. ;
Chitnis, Tanuja ;
Guttmann, Charles R. G. .
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (14) :1841-1849
[10]   The neuroimmune basis of fatigue [J].
Dantzer, Robert ;
Heijnen, Cobi Johanna ;
Kavelaars, Annemieke ;
Laye, Sophie ;
Capuron, Lucile .
TRENDS IN NEUROSCIENCES, 2014, 37 (01) :39-46